Furthermore, gene expression patterns of CD19 CAR-T cells in relapsed/refractory childhood pre-B cell acute lymphoblastic leukemia (R/R B-ALL) patients have revealed valuable insights into the memory-like state and the use of chimeric switch receptors (CARP) for enhancing anti-cancer activity (41, 42). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.